Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin, Pioglitazone and Sitagliptin in Type 2 Diabetes
NCT01895569Phase 4Unknown
- Sponsor
- University of Pavia
- Start
- Jun 2013
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of metformin, pioglitazone, sitagliptin in type 2 diabetes mellitus (T2DM), sponsored by University of Pavia. Status: unknown.
02
Drugs
metforminpioglitazonesitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01895569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01895569.